Measuring Human Lipid Metabolism Using Deuterium Labeling: In Vivo and In Vitro Protocols

  • Katherine E. PinnickEmail author
  • Pippa J. Gunn
  • Leanne HodsonEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1862)


Stable isotopes are powerful tools for tracing the metabolic fate of molecules in the human body. In this chapter, we focus on the use of deuterium (2H), a stable isotope of hydrogen, in the study of human lipid metabolism within the liver in vivo in humans and in vitro using hepatocyte cellular models. The measurement of de novo lipogenesis (DNL) will be focussed on, as the synthesis of fatty acids, specifically palmitate, has been gathering momentum as being implicated in cellular dysfunction, which may be involved in the development of non-alcoholic fatty liver disease (NAFLD). Therefore, this chapter focusses specifically on the use of 2H2O (heavy water) to measure hepatic DNL.

Key words

Stable isotopes Deuterium Human lipid metabolism De novo lipogenesis 


  1. 1.
    Hellerstein MK, Schwarz JM, Neese RA (1996) Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 16:523–557CrossRefGoogle Scholar
  2. 2.
    Wilke MS, French MA, Goh YK et al (2009) Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia 52(8):1628–1637CrossRefGoogle Scholar
  3. 3.
    Solinas G, Boren J, Dulloo AG (2015) De novo lipogenesis in metabolic homeostasis: more friend than foe? Mol Metab 4(5):367–377CrossRefGoogle Scholar
  4. 4.
    Schoenheimer R (1937) The investigation of intermediary metabolism with the aid of heavy hydrogen: Harvey lecture, January 21, 1937. Bull N Y Acad Med 13(5):272–295PubMedPubMedCentralGoogle Scholar
  5. 5.
    Schoenheimer R, Rittenberg D (1935) Deuterium as an indicator in the study of intermediary metabolism. Science 82(2120):156–157CrossRefGoogle Scholar
  6. 6.
    Donnelly KL, Smith CI, Schwarzenberg SJ et al (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5):1343–1351CrossRefGoogle Scholar
  7. 7.
    Barrows BR, Parks EJ (2006) Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab 91(4):1446–1452CrossRefGoogle Scholar
  8. 8.
    Diraison F, Moulin P, Beylot M (2003) Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 29(5):478–485CrossRefGoogle Scholar
  9. 9.
    Lambert JE, Ramos-Roman MA, Browning JD et al (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146(3):726–735CrossRefGoogle Scholar
  10. 10.
    Lee JJ, Lambert JE, Hovhannisyan Y et al (2015) Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am J Clin Nutr 101(1):34–43CrossRefGoogle Scholar
  11. 11.
    Pramfalk C, Pavlides M, Banerjee R et al (2015) Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher propensity for NAFLD in men. J Clin Endocrinol Metab 100(12):4425–4433CrossRefGoogle Scholar
  12. 12.
    Pramfalk C, Pavlides M, Banerjee R et al (2016) Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults. Diabetes 65(7):1858–1867CrossRefGoogle Scholar
  13. 13.
    Timlin MT, Parks EJ (2005) Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am J Clin Nutr 81(1):35–42CrossRefGoogle Scholar
  14. 14.
    Gunn PJ, Green CJ, Pramfalk C et al (2017) In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum. Physiol Rep 5(24):e13532CrossRefGoogle Scholar
  15. 15.
    Burdge GC, Wright P, Jones AE et al (2000) A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 84(5):781–787PubMedGoogle Scholar
  16. 16.
    Choi GT, Casu M, Gibbons WA (1993) N.m.r. lipid profiles of cells, tissues and body fluids. Neutral, non-acidic and acidic phospholipid analysis of Bond Elut chromatographic fractions. Biochem J 290(Pt 3):717–721CrossRefGoogle Scholar
  17. 17.
    Semple RK, Sleigh A, Murgatroyd PR et al (2009) Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119(2):315–322PubMedPubMedCentralGoogle Scholar
  18. 18.
    Diraison F, Pachiaudi C, Beylot M (1997) Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom 32(1):81–86CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill HospitalUniversity of OxfordOxfordUK

Personalised recommendations